Diabetic complications

About us

The 7th International Conference on Diabetic Complications 2027 warmly invites participants, researchers, healthcare professionals, academicians, and industry experts from across the globe to attend and share their valuable insights, research findings, and recent advancements in the field of Diabetes and Diabetic Complications. Based on the theme “Advancing Diabetes Complication Research: Innovative Strategies for Prevention, Early Diagnosis, and Comprehensive Patient Care,” the conference will be held on July 15–16, 2027, in Barcelona, Spain.

We are pleased to welcome Diabetologists, Endocrinologists, Physicians, Researchers, Scientists, Healthcare Professionals, Pharmacologists, Nutritionists, and Specialists in diabetes and related fields to participate in this international gathering.

The Diabetic Complications 2027 aims to bring together leading academicians, research scholars, healthcare practitioners, and industry professionals to exchange knowledge, share their experiences, and discuss the latest scientific developments and innovative approaches in diabetes research and management. The conference will provide an excellent platform for networking, collaboration, and exploring emerging technologies and treatment strategies.

Scope and Importance:

The Diabetic Complications 2027 aims to explore the latest advancements in diabetes research, prevention, diagnosis, and treatment of diabetes-related complications. The conference will highlight innovative approaches to managing complications such as diabetic neuropathy, nephropathy, retinopathy, cardiovascular diseases, and diabetic foot disorders.

It will also focus on advancements in personalized medicine, early screening, innovative therapeutic approaches, and comprehensive patient care. The conference provides a multidisciplinary platform for academicians, researchers, clinicians, and healthcare professionals to exchange scientific knowledge and discuss solutions to current challenges in diabetes management.

Why to Attend?

The Diabetic Complications 2027 offers an excellent opportunity to connect with international experts and professionals, exchange research findings, and explore the latest developments in the field of diabetes and its complications.

Participants will have the opportunity to gain insights into emerging research, innovative treatment approaches, clinical practices, and advanced technologies related to:

• Diabetes Research and Management
• Diabetic Neuropathy
• Diabetic Nephropathy
• Diabetic Retinopathy
• Cardiovascular Complications of Diabetes
• Diabetic Foot and Wound Care
• Diabetes Prevention and Early Diagnosis
• Insulin Therapy and New Treatment Approaches
• Endocrinology and Metabolic Disorders
• Personalized Medicine and Patient Care

Who Can Attend?

The Diabetic Complications 2027 welcomes individuals and professionals with an interest in diabetes research, endocrinology, healthcare, and related medical disciplines.

It provides a global platform for professionals to discuss current challenges, exchange scientific evidence, share innovative ideas, and establish valuable professional collaborations.

Target Audience:

• Researchers and Students
• Diabetologists
• Endocrinologists
• Healthcare Professionals
• Medical Practitioners
• Academicians and Professors
• Clinical Researchers
• Pharmaceutical Experts
• Nutritionists and Dietitians
• Diabetes Educators
• Physicians and Specialists
• Biotechnology and Medical Science Professionals

Sessions/ Tracks

Track 1: Diabetes Research and Pathophysiology

Diabetes mellitus is a chronic metabolic disorder characterized by elevated blood glucose levels resulting from impaired insulin secretion, insulin resistance, or both. Understanding the pathophysiology of diabetes is essential for developing effective prevention and treatment strategies. This track focuses on the molecular, cellular, genetic, and metabolic mechanisms involved in the development and progression of diabetes.

Track 2: Diabetic Neuropathy and Neurological Complications

Diabetic neuropathy is one of the most common complications of diabetes, affecting the peripheral and autonomic nervous systems. Prolonged exposure to elevated blood glucose levels can damage nerves and blood vessels, resulting in pain, numbness, tingling sensations, and loss of sensation. This track highlights recent advances in the diagnosis, prevention, and management of diabetic neuropathy.

Track 3: Diabetic Nephropathy and Kidney Diseases

Diabetic nephropathy is a serious microvascular complication of diabetes and a leading cause of chronic kidney disease and end-stage renal disease. Persistent hyperglycemia, hypertension, and metabolic abnormalities contribute to progressive kidney damage and impaired renal function. This track focuses on the underlying mechanisms, early biomarkers, diagnostic approaches, and therapeutic interventions associated with diabetic kidney disease.

Track 4: Diabetic Retinopathy and Eye Complications

Diabetic retinopathy is a major microvascular complication of diabetes that affects the blood vessels of the retina and can lead to progressive vision impairment and blindness. Early detection and appropriate treatment are essential to prevent irreversible visual damage. This track explores recent advancements in the pathogenesis, screening, diagnosis, and treatment of diabetic eye diseases. Key topics include retinal vascular abnormalities, diabetic macular edema, proliferative diabetic retinopathy, retinal imaging, artificial intelligence-assisted screening, laser therapy, and anti-VEGF treatments.

Track 5: Cardiovascular Complications of Diabetes

People with diabetes are at an increased risk of developing cardiovascular diseases due to metabolic disturbances, chronic inflammation, endothelial dysfunction, and vascular damage. Cardiovascular complications include coronary artery disease, heart failure, stroke, hypertension, and peripheral arterial disease. This track focuses on the relationship between diabetes and cardiovascular health, including underlying mechanisms, risk assessment, early diagnosis, and advanced treatment approaches.

Track 6: Diabetic Foot Complications and Wound Care

Diabetic foot complications are among the most serious consequences of long-term diabetes and can result in chronic ulcers, infections, tissue damage, and lower-limb amputations. Peripheral neuropathy, poor circulation, and impaired wound healing are major contributing factors. This track highlights the latest research and clinical developments in diabetic foot prevention, assessment, diagnosis, and treatment. Topics include diabetic foot ulcers, peripheral arterial disease, wound healing mechanisms, infection management, tissue regeneration, advanced wound dressings, and regenerative medicine.

Track 7: Diabetes Prevention, Early Diagnosis and Screening

Early diagnosis and preventive interventions play a vital role in reducing the global burden of diabetes and its associated complications. Identifying individuals at risk and implementing timely screening programs can help prevent or delay disease progression and related health problems. This track focuses on innovative screening methods, early diagnostic biomarkers, genetic risk assessment, continuous glucose monitoring, and advanced diagnostic technologies. It also explores the importance of lifestyle modifications, nutritional interventions, physical activity, and preventive healthcare programs.

Track 8: Innovative Diabetes Treatments and Therapeutic Approaches

Advancements in diabetes treatment have significantly improved glycemic control and reduced the risk of diabetes-related complications. This track focuses on emerging pharmacological and non-pharmacological treatment strategies, including insulin therapy, oral antidiabetic medications, GLP-1 receptor agonists, SGLT2 inhibitors, combination therapies, and personalized treatment approaches. It also explores developments in artificial pancreas systems, insulin delivery technologies, continuous glucose monitoring, beta-cell replacement, and regenerative medicine.

Track 9: Diabetes, Obesity and Metabolic Disorders

Obesity and metabolic disorders are closely associated with the development of type 2 diabetes and its related complications. Insulin resistance, abnormal lipid metabolism, chronic inflammation, and hormonal imbalances contribute to metabolic dysfunction and increased disease risk. This track explores the complex relationship between obesity, diabetes, metabolic syndrome, and other endocrine disorders. Topics include metabolic regulation, adipose tissue dysfunction, bariatric surgery, weight management, nutritional therapies, and metabolic interventions.

Track 10: Personalized Medicine and Comprehensive Diabetes Patient Care

Personalized medicine is transforming diabetes management through individualized treatment strategies based on genetic, metabolic, clinical, and lifestyle factors. Comprehensive diabetes care requires multidisciplinary collaboration, continuous monitoring, patient education, and effective management of associated complications. This track highlights precision medicine, pharmacogenomics, digital health technologies, telemedicine, artificial intelligence in diabetes care, and patient-centered healthcare approaches. It also addresses long-term disease monitoring, medication adherence, psychological well-being, and integrated care models.

Market Analysis

Diabetes mellitus has emerged as one of the fastest-growing global healthcare challenges, creating an increasing demand for advanced diagnostic technologies, innovative treatment approaches, preventive strategies, and comprehensive patient care. The rising prevalence of diabetes and its associated complications has significantly increased the need for research, clinical innovation, pharmaceutical development, and healthcare investment worldwide.

According to the International Diabetes Federation (IDF) Diabetes Atlas, 11th Edition (2025), approximately 589 million adults aged 20–79 years were living with diabetes globally in 2024. This number is projected to increase to approximately 853 million by 2050, highlighting the growing demand for effective diabetes prevention, early diagnosis, and long-term complication management.

The global economic burden of diabetes is also substantial. Diabetes-related healthcare expenditure exceeded USD 1 trillion in 2024, reflecting the increasing need for accessible healthcare services, advanced medications, monitoring technologies, and specialized treatment facilities.

Research and Innovation Opportunities

The diabetes research landscape is rapidly evolving, with increasing attention toward precision medicine, personalized treatment, advanced biomarkers, genetic research, and novel therapeutic interventions. Innovations in GLP-1 receptor agonists, SGLT2 inhibitors, insulin delivery systems, and continuous glucose monitoring are contributing to improvements in diabetes management and complication prevention.Furthermore, developments in artificial intelligence, telemedicine, digital health platforms, and predictive analytics are creating new opportunities for early diagnosis, continuous patient monitoring, and personalized healthcare delivery.

Growing Demand for Diabetic Complication Management

Diabetes-related complications, including cardiovascular diseases, diabetic nephropathy, neuropathy, retinopathy, and diabetic foot disorders, represent major challenges for healthcare systems worldwide. Early screening, timely intervention, and multidisciplinary patient management are becoming increasingly important in reducing disease progression and improving patient outcomes.

The growing demand for specialized diabetic complication management is encouraging collaboration among healthcare professionals, research institutions, pharmaceutical companies, biotechnology organizations, medical device manufacturers, and diagnostic technology developers.

Future Market Opportunities

The future of diabetes care will increasingly focus on preventive healthcare, early diagnosis, personalized treatment, advanced monitoring systems, and integrated patient management. Growing investments in pharmaceutical research, medical technologies, clinical trials, and healthcare infrastructure are expected to support further innovation in diabetes and its associated complications.

The 7th International Conference on Diabetic Complications 2027 will provide an international platform for researchers, academicians, clinicians, healthcare professionals, pharmaceutical experts, and industry representatives to exchange knowledge, present scientific advancements, discuss emerging market trends, and explore collaborative opportunities. With its theme, “Advancing Diabetes Complication Research: Innovative Strategies for Prevention, Early Diagnosis, and Comprehensive Patient Care,” the conference aims to contribute to the advancement of diabetes research and encourage innovative solutions for improving global diabetes care.